Is surgery an option for early stage Bladder Cancer

Surgery for Early-Stage Bladder Cancer

Yes, surgery is absolutely an option for early-stage bladder cancer, and in fact, it's often a primary treatment approach. Let me explain what this typically looks like.

Initial Diagnostic Surgery: TURBT

When bladder cancer is first suspected, the standard diagnostic procedure is called TURBT (transurethral resection of bladder tumor). According to the NCCN Guidelines, this procedure serves two important purposes:

1. Confirms the diagnosis - It allows doctors to see the tumor and take tissue samples
2. Determines how deep the cancer has invaded - The surgeon removes visible tumor and samples muscle tissue to assess whether the cancer has invaded the muscle layer of the bladder

This is done under anesthesia, and the surgeon uses a special instrument passed through the urethra (the tube that carries urine). This means no external incisions are needed.

What "Early Stage" Means

Early-stage bladder cancer typically refers to:

• Non-muscle invasive tumors (Ta, T1, or CIS - carcinoma in situ) - these haven't invaded the muscle layer
• Stage I-II disease - localized to the bladder without spread to lymph nodes or distant organs

Treatment Options for Early-Stage Disease

According to NCCN Guidelines, early-stage bladder cancer can be managed with:

1. TURBT Alone

• For select patients with small, low-grade tumors without muscle invasion
• Requires close surveillance with repeat cystoscopies (camera exams of the bladder)

2. TURBT + Intravesical Therapy

• After TURBT, medication is placed directly into the bladder (usually BCG - bacillus Calmette-Guérin, an immunotherapy)
• This reduces recurrence risk significantly
• This is the most common approach for higher-risk early-stage tumors

3. Radical Cystectomy (Bladder Removal)

• Reserved for cases where:
  • Cancer recurs despite BCG treatment
  • High-grade disease is present
  • Carcinoma in situ (CIS) is found
  • Patient preference for definitive treatment

Key Point About Surveillance

The NCCN Guidelines emphasize that early-stage bladder cancer has a high recurrence rate (meaning it can come back), so regular follow-up cystoscopies are essential. About 50-70% of patients with early-stage disease will have recurrence, which is why close monitoring is critical.

Questions to Ask Your Healthcare Team

1. What stage is my cancer, and has it invaded the muscle layer?
2. Am I a candidate for TURBT alone, or do you recommend intravesical therapy after TURBT?
3. What is my recurrence risk based on my specific tumor characteristics?
4. How often will I need follow-up cystoscopies, and for how long?
5. If my cancer recurs, what are my options at that point?

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.